Targeting KRAS mutations in pancreatic cancer: opportunities for future strategiesFRONTIERS IN MEDICINEIF32024-03-219OAAI
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review曲妥珠单抗Deruxtecan在HER2-Positive不可切除或转移性乳腺癌患者治疗中的作用: 一项循证综述breast cancerIF3.42021-02-0118OAAI
Prognostic indicators for COVID-19 related deaths in patients with cancerANNALS OF ONCOLOGYIF65.42020-09-011OAAI
Final results from a prospective study examining exhaled breath alcohol levels following weekly paclitaxel chemotherapyANNALS OF ONCOLOGYIF65.42020-09-010OAAI
Delivery of systemic anti-cancer therapy during the COVID-19 pandemicANNALS OF ONCOLOGYIF65.42020-09-010OAAI
Exposure-response relations of α-amylase sensitisation in British bakeries and flour millsOCCUPATIONAL AND ENVIRONMENTAL MEDICINEIF3.11999-11-011OAAI